These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14735294)

  • 1. Visuospatial memory impairments in users of MDMA ('ecstasy').
    Wareing M; Murphy PN; Fisk JE
    Psychopharmacology (Berl); 2004 May; 173(3-4):391-7. PubMed ID: 14735294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
    Wareing M; Fisk JE; Murphy P; Montgomery C
    Hum Psychopharmacol; 2005 Mar; 20(2):115-23. PubMed ID: 15641126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory.
    Murphy PN; Erwin PG; Maciver L; Fisk JE; Larkin D; Wareing M; Montgomery C; Hilton J; Tames FJ; Bradley B; Yanulevitch K; Ralley R
    Hum Psychopharmacol; 2011 Oct; 26(7):460-9. PubMed ID: 21898599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected.
    Kuypers KP; Ramaekers JG
    Psychopharmacology (Berl); 2007 Jan; 189(4):557-63. PubMed ID: 16508761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Working memory deficits in current and previous users of MDMA ('ecstasy').
    Wareing M; Fisk JE; Murphy PN
    Br J Psychol; 2000 May; 91 ( Pt 2)():181-8. PubMed ID: 10832513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information processing speed in ecstasy (MDMA) users.
    Wareing M; Fisk JE; Montgomery C; Murphy PN; Chandler MD
    Hum Psychopharmacol; 2007 Mar; 22(2):81-8. PubMed ID: 17295197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.
    Murphy PN; Bruno R; Ryland I; Wareing M; Fisk JE; Montgomery C; Hilton J
    Hum Psychopharmacol; 2012 Mar; 27(2):113-38. PubMed ID: 22389076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal working memory deficits in current and previous users of MDMA.
    Wareing M; Fisk JE; Murphy P; Montgomery C
    Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visuospatial working memory impairment in current and previous ecstasy/polydrug users.
    Fisk JE; Montgomery C; Hadjiefthyvoulou F
    Hum Psychopharmacol; 2011; 26(4-5):313-21. PubMed ID: 22700465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
    J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV; Verheyden SL
    Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syllogistic reasoning performance in MDMA (Ecstasy) users.
    Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
    Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of learning, memory, and executive function in new MDMA users.
    Wagner D; Becker B; Koester P; Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
    Blagrove M; Seddon J; George S; Parrott AC; Stickgold R; Walker MP; Jones KA; Morgan MJ
    J Psychopharmacol; 2011 Apr; 25(4):465-77. PubMed ID: 20615932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.
    Montgomery C; Fisk JE; Newcombe R; Murphy PN
    Psychopharmacology (Berl); 2005 Oct; 182(2):262-76. PubMed ID: 16010539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
    Fisk JE; Montgomery C; Wareing M; Murphy PN
    Hum Psychopharmacol; 2006 Aug; 21(6):355-66. PubMed ID: 16915582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.